Different Modes of Cell-killing Action between DNA Topoisomerase I and II Inhibitors Revealed by Kinetic Analysis

This publication has 21 references indexed in Scilit:

• UCE6, A new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.
  The Journal of Antibiotics, 1993
• Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives
  Biochemistry, 1992
• Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
  Biochemical Pharmacology, 1991
• Cell death induced by topoisomerase inhibitors: Role of calcium in mammalian cells
  Biochemical Pharmacology, 1991
• Kinetic Analysis of 5‐Fluorouracil Action against Various Cancer Cells
  Japanese Journal of Cancer Research, 1990
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino) methane-sulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase ii in a murine mastocytoma cell line
  Biochemical Pharmacology, 1989
• Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product
  Cancer Chemotherapy and Pharmacology, 1988
• Abrogation of etoposide-mediated cytotoxicity by cycloheximide
  Biochemical Pharmacology, 1988
• Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
  Proceedings of the National Academy of Sciences, 1988